| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Fernanda Flores-Alfaro, Sergio A Castillo-Torres, Alfonso H Gil-Valadez, Romulo Ramírez-Gutiérre. Odd O in NMO: isolated Horner syndrome without optic neuritis in a patient with neuromyelitis optica. BMJ case reports. vol 12. issue 9. 2020-02-13. PMID:31519725. |
odd o in nmo: isolated horner syndrome without optic neuritis in a patient with neuromyelitis optica. |
2020-02-13 |
2023-08-13 |
Not clear |
| Ping Lu, Ting Yuan, Xilan Liu, Guohong Tian, Jibin Zhang, Yan Sh. Role of Diffusional Kurtosis Imaging in Differentiating Neuromyelitis Optica-Related and Multiple Sclerosis-Related Acute Optic Neuritis: Comparison With Diffusion-Weighted Imaging. Journal of computer assisted tomography. vol 44. issue 1. 2020-01-23. PMID:31939881. |
the discrimination between neuromyelitis optica (nmo)- and multiple sclerosis (ms)-related acute optic neuritis (on) after the first presentation is difficult in clinical practice. |
2020-01-23 |
2023-08-13 |
Not clear |
| Mark Lipphardt, Johannes Mühlhausen, Bernd Kitze, Franz Heigl, Erich Mauch, Hans-Joachim Helms, Gerhard A Müller, Michael J Koziole. Immunoadsorption or plasma exchange in steroid-refractory multiple sclerosis and neuromyelitis optica. Journal of clinical apheresis. vol 34. issue 4. 2020-01-15. PMID:30698295. |
plasma exchange (pe) and immunoadsorption (ia) are alternative treatments of steroid-refractory relapses of multiple sclerosis (ms) or neuromyelitis optica (nmo). |
2020-01-15 |
2023-08-13 |
Not clear |
| Khaled Deeb, Jessika Eby, Jose Labault-Santiag. Demyelinating syndrome in systemic sclerosis and neuromyelitis optica. BMC neurology. vol 19. issue 1. 2019-12-20. PMID:31607267. |
transverse myelitis was evident on mri and serological studies were consistent with neuromyelitis optica (nmo) based on nmo-igg sero-positivity. |
2019-12-20 |
2023-08-13 |
Not clear |
| James M Hillis, Farrah J Matee. Neuromyelitis optica after splenectomy: A secondary autoimmune phenomenon. Journal of neuroimmunology. vol 330. 2019-12-03. PMID:30884276. |
we describe the case of a 53-year-old woman who undergoes total splenectomy and later presents with aquaporin-4 antibody positive neuromyelitis optica (nmo). |
2019-12-03 |
2023-08-13 |
Not clear |
| Xiaoming Yao, Matthew S Adams, Peter D Jones, Chris J Diederich, Alan S Verkma. Noninvasive, Targeted Creation of Neuromyelitis Optica Pathology in AQP4-IgG Seropositive Rats by Pulsed Focused Ultrasound. Journal of neuropathology and experimental neurology. vol 78. issue 1. 2019-11-29. PMID:30500945. |
neuromyelitis optica spectrum disorders (herein called nmo) is an autoimmune disease of the cns characterized by astrocyte injury, inflammation, and demyelination. |
2019-11-29 |
2023-08-13 |
human |
| John W Prineas, Sandra Le. Multiple Sclerosis: Destruction and Regeneration of Astrocytes in Acute Lesions. Journal of neuropathology and experimental neurology. vol 78. issue 2. 2019-11-29. PMID:30605525. |
also examined were nonnecrotic early lesions in 3 patients with neuromyelitis optica (nmo). |
2019-11-29 |
2023-08-13 |
Not clear |
| Francesco Pisani, Laura Simone, Maria Grazia Mola, Manuela De Bellis, Maria Mastrapasqua, Maddalena Ruggieri, Maria Trojano, Grazia Paola Nicchia, Maria Svelto, Antonio Friger. Host-Cell Type Dependent Features of Recombinant Human Aquaporin-4 Orthogonal Arrays of Particles-New Insights for Structural and Functional Studies. Cells. vol 8. issue 2. 2019-11-27. PMID:30717425. |
native size exclusion chromatography was employed to isolate and analyze authentically folded oaps, and neuromyelitis optica (nmo)-specific sandwich elisa was developed to test oap-integrity. |
2019-11-27 |
2023-08-13 |
human |
| T O Simaniv, A A Vorob'eva, N V Smirnova, N A Zigangirova, M N Zakharov. [Neuromyelitis optica and aquaporin-associated syndromes]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. vol 115. issue 2 Pt 2. 2019-11-20. PMID:26081334. |
identification of aquaporin-4 antibodies in neuromyelitis optica (nmo) is highly important to provide early diagnosis for starting pathogenetic treatment, and for differential diagnosis in neuromyelitis optica spectrum disorders (nmo-sd). |
2019-11-20 |
2023-08-13 |
Not clear |
| Eoin P Flanagan, Philippe Cabre, Brian G Weinshenker, Jennifer St Sauver, Debra J Jacobson, Masoud Majed, Vanda A Lennon, Claudia F Lucchinetti, Andrew McKeon, Marcelo Matiello, Nilifur Kale, Dean M Wingerchuk, Jay Mandrekar, Jessica A Sagen, James P Fryer, Angala Borders Robinson, Sean J Pittoc. Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum. Annals of neurology. vol 79. issue 5. 2019-11-20. PMID:26891082. |
neuromyelitis optica (nmo) and its spectrum disorders (nmosd) are inflammatory demyelinating diseases (idds) with a specific biomarker, aquaporin-4-immunoglobulin g (aqp4-igg). |
2019-11-20 |
2023-08-13 |
Not clear |
| Marina Herwerth, Sudhakar Reddy Kalluri, Rajneesh Srivastava, Tatjana Kleele, Selin Kenet, Zsolt Illes, Doron Merkler, Jeffrey L Bennett, Thomas Misgeld, Bernhard Hemme. In vivo imaging reveals rapid astrocyte depletion and axon damage in a model of neuromyelitis optica-related pathology. Annals of neurology. vol 79. issue 5. 2019-11-20. PMID:26946517. |
neuromyelitis optica (nmo) is an autoimmune disease of the central nervous system, which resembles multiple sclerosis (ms). |
2019-11-20 |
2023-08-13 |
Not clear |
| Jiwon Yang, Sung Min Kim, Yoo-Jin Kim, So Young Cheon, Boram Kim, Kyeong Cheon Jung, Kyung Seok Par. Accuracy of the Fluorescence-Activated Cell Sorting Assay for the Aquaporin-4 Antibody (AQP4-Ab): Comparison with the Commercial AQP4-Ab Assay Kit. PloS one. vol 11. issue 9. 2019-11-20. PMID:27658059. |
the aquaporin-4 antibody (aqp4-ab) is a disease-specific autoantibody to neuromyelitis optica (nmo). |
2019-11-20 |
2023-08-13 |
Not clear |
| Vahid Davoudi, Kiandokht Keyhanian, Riley M Bove, Tanuja Chitni. Immunology of neuromyelitis optica during pregnancy. Neurology(R) neuroimmunology & neuroinflammation. vol 3. issue 6. 2019-11-20. PMID:27761482. |
anti-aquaporin-4 (aqp4) autoantibody plays a key role in the pathogenesis of neuromyelitis optica (nmo). |
2019-11-20 |
2023-08-13 |
Not clear |
| Yukio Takeshita, Birgit Obermeier, Anne C Cotleur, Simona F Spampinato, Fumitaka Shimizu, Erin Yamamoto, Yasuteru Sano, Thomas J Kryzer, Vanda A Lennon, Takashi Kanda, Richard M Ransohof. Effects of neuromyelitis optica-IgG at the blood-brain barrier in vitro. Neurology(R) neuroimmunology & neuroinflammation. vol 4. issue 1. 2019-11-20. PMID:28018943. |
to address the hypothesis that physiologic interactions between astrocytes and endothelial cells (ec) at the blood-brain barrier (bbb) are afflicted by pathogenic inflammatory signaling when astrocytes are exposed to aquaporin-4 (aqp4) antibodies present in the immunoglobulin g (igg) fraction of serum from patients with neuromyelitis optica (nmo), referred to as nmo-igg. |
2019-11-20 |
2023-08-13 |
Not clear |
| Paola Valentino, Fabiana Marnetto, Letizia Granieri, Marco Capobianco, Antonio Bertolott. Aquaporin-4 antibody titration in NMO patients treated with rituximab: A retrospective study. Neurology(R) neuroimmunology & neuroinflammation. vol 4. issue 2. 2019-11-20. PMID:28054001. |
we undertook an observational retrospective study to investigate the usefulness of aquaporin-4 (aqp4) antibodies (ab) titration in the management of patients with neuromyelitis optica (nmo) treated with rituximab (rtx) by studying (1) the correlation between aqp4-ab titer and disease activity, (2) the influence of rtx on antibody levels, and (3) the association between aqp4-ab levels and responsiveness to rtx. |
2019-11-20 |
2023-08-13 |
Not clear |
| Zhen Wang, Yaping Ya. Immunopathogenesis in Myasthenia Gravis and Neuromyelitis Optica. Frontiers in immunology. vol 8. 2019-11-20. PMID:29312313. |
myasthenia gravis (mg) and neuromyelitis optica (nmo) are autoimmune channelopathies of the peripheral neuromuscular junction (nmj) and central nervous system (cns) that are mainly mediated by humoral immunity against the acetylcholine receptor (achr) and aquaporin-4 (aqp4), respectively. |
2019-11-20 |
2023-08-13 |
Not clear |
| Simone Mader, Lior Brimberg, John N Soltys, Jeffrey L Bennett, Betty Diamon. Mutations of Recombinant Aquaporin-4 Antibody in the Fc Domain Can Impair Complement-Dependent Cellular Cytotoxicity and Transplacental Transport. Frontiers in immunology. vol 9. 2019-11-20. PMID:30057582. |
brain-reactive antibodies to the water channel protein aquaporin-4 (aqp4) are a hallmark finding in neuromyelitis optica (nmo), a neurological disease that predominantly affects women, many of whom are of childbearing age. |
2019-11-20 |
2023-08-13 |
Not clear |
| Tzu-Lun Huang, Kung-Hung Lin, Jia-Kang Wang, Rong-Kung Tsa. Treatment strategies for neuromyelitis optica. Ci ji yi xue za zhi = Tzu-chi medical journal. vol 30. issue 4. 2019-11-20. PMID:30305782. |
neuromyelitis optica (nmo) is an autoimmune demyelinating disease with pathogenic autoantibodies that act against the astrocyte water channel protein, i.e. |
2019-11-20 |
2023-08-13 |
Not clear |
| Ilana Katz Sand, Michelle T Fabian, Russell Telford, Thomas A Kraus, Mirna Chehade, Madhan Masilamani, Thomas Moran, Colleen Farrell, Shelly Ebel, Lawrence J Cook, John Rose, Fred D Lubli. Open-label, add-on trial of cetirizine for neuromyelitis optica. Neurology(R) neuroimmunology & neuroinflammation. vol 5. issue 2. 2019-11-20. PMID:30426035. |
this pilot study preliminarily examined the efficacy and tolerability of cetirizine as an add-on to standard therapy for neuromyelitis optica (nmo). |
2019-11-20 |
2023-08-13 |
Not clear |
| Fumitaka Shimizu, Hideaki Nishihara, Takashi Kand. Blood-brain barrier dysfunction in immuno-mediated neurological diseases. Immunological medicine. vol 41. issue 3. 2019-11-20. PMID:30938273. |
pathological bbb dysfunction is a critical step of the disease process in several immuno-mediated neurological diseases, including multiple sclerosis (ms), neuromyelitis optica (nmo), neuropsychiatric systemic lupus erythematosus (npsle) and neuro-behçet diseases. |
2019-11-20 |
2023-08-13 |
Not clear |